Card R T, Holmes I H, Sugarman R G, Storb R, Thomas E D
Exp Hematol. 1980 Jan;8(1):57-60.
A 29-year-old woman with severe idiopathic aplastic anemia was given immunosuppressive therapy with procarbazine, 37.5 mg/kg, antithymocyte globulin, 36 mg IgG/kg, and cyclophosphamide, 200 mg/kg. This was followed by a marrow transplant from her HLA identical sister, immunosuppressive therapy with intermittent methotrexate for 3 months postgrafting and ultimate restoration of hematopoiesis. Two years after transplantation the patient delivered a healthy male infant. This is the first successful pregnancy after a high dose chemotherapy and marrow transplantation for treatment of aplastic anemia.
一名29岁患有严重特发性再生障碍性贫血的女性接受了免疫抑制治疗,使用丙卡巴肼,剂量为37.5毫克/千克,抗胸腺细胞球蛋白,剂量为36毫克免疫球蛋白/千克,以及环磷酰胺,剂量为200毫克/千克。随后接受了来自其 HLA 相同的姐姐的骨髓移植,移植后使用间断甲氨蝶呤进行免疫抑制治疗3个月,最终造血功能恢复。移植两年后,该患者产下一名健康男婴。这是首例经大剂量化疗和骨髓移植治疗再生障碍性贫血后成功妊娠的案例。